James Patrick Kelly has sold VNDA and made no open-market buys since Jan 2016
EVP and CFO at Vanda Pharmaceuticals Inc.
SEC CIK 0001506314 · Filings on SEC.gov ↗
$0Bought
$1.2MSold
NoneLast buy
Every filing
8 filings since Jan 2016, newest first
VNDASell
Vanda Pharmaceuticals Inc.
EVP and CFO
$195K−9.0%Mar 4
VNDASell
Vanda Pharmaceuticals Inc.
EVP and CFO
$64K−2.0%Jan 6
VNDASell
Vanda Pharmaceuticals Inc.
EVP and CFO
$274K−6.0%Mar 4
VNDASell
Vanda Pharmaceuticals Inc.
EVP and CFO
$160K−3.0%Jan 4
VNDASell
Vanda Pharmaceuticals Inc.
EVP and CFO
$160K−4.0%Mar 2
VNDASell
Vanda Pharmaceuticals Inc.
EVP and CFO
$140K−5.0%Jan 4
VNDASell
Vanda Pharmaceuticals Inc.
SVP, CFO and Treasurer
$169K−14.0%Jan 5
VNDASell
Vanda Pharmaceuticals Inc.
SVP, CFO, Sec, Treasurer
$86K−14.0%Jan 6
Filings come from SEC EDGAR. Not investment advice.